XML 18 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
REVENUES        
Collaboration and license $ 3,920,675 $ 12,884,261
OPERATING EXPENSES        
Research and development 3,517,223 3,755,158 10,362,756 12,928,391
General and administrative 1,984,446 1,474,019 6,769,994 5,176,794
Gain on sale of Vyleesi (2,500,000)
Gain on purchase commitment (416,000) (416,000)
Total operating expenses 5,501,669 4,813,177 17,132,750 15,189,185
Loss from operations (1,580,994) (4,813,177) (4,248,489) (15,189,185)
OTHER INCOME (EXPENSE)        
Investment income 149,275 31,452 232,943 139,072
Foreign currency transaction loss (27,900) (15,900)
Interest expense (1,268) (1,795) (3,768) (11,538)
Total other income (expense), net 148,007 1,757 229,175 111,634
NET LOSS $ (1,432,987) $ (4,811,420) $ (4,019,314) $ (15,077,551)
Basic net loss per common share $ (0.37) $ (9.13) $ (1.63) $ (33.89)
Diluted net loss per common share $ (0.37) $ (9.13) $ (1.63) $ (33.89)
Weighted average number of common shares outstanding used in computing basic net loss per common share 3,911,941 526,891 2,463,915 444,903
Weighted average number of common shares outstanding used in computing basic net loss per common share 3,911,941 526,891 2,463,915 444,903